Bright Path Laboratories

Global manufacturing capacity for active pharmaceutical ingredients remains concentrated. Good analysis @USPharmacopeia https://lnkd.in/ekW37THJ Bright Path’s patented STT™ continuous flow technology is revolutionizing US pharmaceutical manufacturing. We're solving drug shortages through rapid development & scale-up, reducing production time from months to weeks. Proud to help secure America's medicine supply chain.  #PharmaInnovation 🇺🇸 #MadeInUSA #manufacturing

Our CEO Tony Quinones recently spoke to over 100 delegates at the Health Equity Forum at the United Nations, during the 79th session of the UN General Assembly. Tony was joined by Dr. Henry Ruiz, Chairman of the Renaissance Medical Foundation (part of DHR Health in McAllen, Texas) in a conversation led by Lili Gil Valletta, that explored the advancement of healthcare out of the lab to the patient. Aligned by the priorities of accelerating innovative technologies and enabling health systems to reshape the supply chain, Tony and Dr. Ruiz shared the powerful stories of Bright Path and DHR Health, and the respective roles each organization are serving in providing superior options for patients and providers. (L-R): Dr. Henry Ruiz, Lili Gil Valleta, Tony Quinones Photo Credit: Health Equity Forum #healthequity #healthaccess #innovation #brightpath #dhrhealth

We're excited to announce that our CEO, Tony Quinones, will be speaking at the 2nd Health Equity Forum hosted at the United Nations during #UNGA79! At Bright Path Labs, we're at the forefront of pharmaceutical innovation, leading the way in advanced manufacturing and continuous flow technology. Our proprietary (STT) reactor is revolutionizing how we produce Advanced Pharmaceutical Ingredients (APIs), making drug manufacturing more efficient, sustainable, and accessible. Tony will be sharing insights on how Bright Path's technologies can contribute to global health equity. He's looking forward to engaging with other industry leaders to explore collaborative ways of building a healthier world for all. Key discussion points will include: ·      How advanced manufacturing can increase access to essential medicines ·      The role of continuous flow chemistry in sustainable pharmaceutical production ·      Leveraging innovation to address global health challenges We're proud to be part of this crucial conversation at the intersection of technology, pharmaceuticals, and global health equity. Join us in our mission to transform pharmaceutical manufacturing and improve health outcomes worldwide. #HealthEquity #PharmaceuticalInnovation #AdvancedManufacturing #ContinuousFlowChemistry #UNGA #GlobalHealth #SDG3 #PharmaTech #API #GreenChemistry #SustainableManufacturing #PharmaceuticalInnovation

A "significant leap forward in pharmaceutical manufacturing" is underway at Bright Path. Read the breaking announcement on BPL's EQUIP-A-Pharma Agreement award from #DARPA in partnership with the #ASPR's Center of Industrial Base Management and Supply Chain (#IBMSC). The potential impacts of this work are far-reaching and can address critical drug shortages more rapidly, enable point-of-need manufacturing to support military operations and countermeasures, enhance the overall resilience of the pharmaceutical supply chain and develop the groundwork for more personalized medicine approaches. #ai #brightpath #drugshortage #health #hhs #impact #innovation #medicine #military #personalizedhealth #pharma #pharmaceutical #publichealth #supplychain #sustainability

Bright Path Labs Develops Potential Life Saving Drug for Children with Rare Disease 

Bright Path Labs Develops Potential Life Saving Drug for Children with Rare Disease 

Bright Path Labs Develops Potential Life Saving Drug for Children with Rare Disease